Bornhäuser, M., Schliemann, C., Schetelig, J., Röllig, C., Kramer, M., Glass, B., . . . Stelljes, M. (2023). Allogeneic hematopoietic cell transplantation vs standard consolidation chemotherapy in patients with intermediate-risk acute myeloid leukemia: A randomized clinical trial: original investigation. JAMA oncology, 9(4), . https://doi.org/10.1001/jamaoncol.2022.7605
Chicago Style (17th ed.) CitationBornhäuser, Martin, et al. "Allogeneic Hematopoietic Cell Transplantation Vs Standard Consolidation Chemotherapy in Patients with Intermediate-risk Acute Myeloid Leukemia: A Randomized Clinical Trial: Original Investigation." JAMA Oncology 9, no. 4 (2023). https://doi.org/10.1001/jamaoncol.2022.7605.
MLA (9th ed.) CitationBornhäuser, Martin, et al. "Allogeneic Hematopoietic Cell Transplantation Vs Standard Consolidation Chemotherapy in Patients with Intermediate-risk Acute Myeloid Leukemia: A Randomized Clinical Trial: Original Investigation." JAMA Oncology, vol. 9, no. 4, 2023, https://doi.org/10.1001/jamaoncol.2022.7605.